Print friendly version
Thrombocytopenia, acquired amegakaryocytic
Other Names for this Disease
- Acquired pure megakaryocytic aplasia
- Severe thrombocytopenia and selective, marked decrease or absence of megakaryocytes
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
 It is so named because the level of the large bone marrow cells that produce platelets, called megakaryocytes, are significantly lower or absent. The course of the condition is variable, but the condition can become life-threatening. Its cause is currently unknown.Acquired amegakaryocytic thrombocytopenia is characterized by severe thrombocytopenia (lack of platelets) with no other blood abnormalities.
Last updated: 6/10/2009
- Bulcahndani D et al.,. Acquired pure megakaryocytic aplasia: Report of a single case treated with Mycophenolate Mofetil. American Journal of Hematology. 2007;
- Felderbauer P et al.,. Case Report: Acquired pure megakaryocytic aplasia: a seoarate haematological disease entity or a syndrome with multiple causes?. Eur J Haematol. 2004;
- MedlinePlus provides lists many resources and provides more information on blood disorders in general that you may find helpful. MedlinePlus is a Web site designed by the National Library of Medicine to help you research your health questions.
- The National Heart Lung and Blood Institute (NHLBI) provides information on thrombocytopenia in general. The NHLBI was created to conduct research and distribute health information on diseases of the heart, blood vessels, lungs, and blood.
In Depth Information
- PubMed is a searchable database of medical literature and lists journal articles that discuss Thrombocytopenia, acquired amegakaryocytic. Click on the link to view a sample search on this topic.